Compound ID | 825
Class: Oxazolidinone
Spectrum of activity: | Gram-positive & Gram-negative |
Institute where first reported: | Pharmacia Corp. and Veriscor (Pfizer, USA) |
Year first mentioned: | 2001 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Was part of a series to identify linezolid analogs, the program seems still active, however, this seem to have been superseded |
External links: | |
Citation: |